1. Controlling metastatic cancer: the role of phytochemicals in cell signaling
   Andrea Kapinova et al, 2019, Journal of Cancer Research and Clinical Oncology CrossRef
2. Unraveling the Epigenetic Role and Clinical Impact of Histone Deacetylases in Neoplasia
   Dimitrios Goutas et al, 2021, Diagnostics CrossRef
3. Class I-Histone Deacetylase (HDAC) Inhibition is Superior to pan-HDAC Inhibition in Modulating Cisplatin Potency in High Grade Serous Ovarian Cancer Cell Lines
   Jan J. Bandolik et al, 2019, International Journal of Molecular Sciences CrossRef
4. Synthesis, cytotoxic activity, and mode of action of new Santacruzamate A analogs
   Silmara N. Andrade et al, 2018, Medicinal Chemistry Research CrossRef
5. Potential of histone deacetylase inhibitors in the control and regulation of prostate, breast and ovarian cancer
   Siddhartha Das Pramanik et al, 2022, Frontiers in Chemistry CrossRef
6. Epigenetic Regulation of p21cip1/waf1 in Human Cancer
   Matthias Ocker et al, 2019, Cancers CrossRef
7. Review the progression of ovarian clear cell carcinoma from the perspective of genomics and epigenomics
   An Tong et al, 2023, Frontiers in Genetics CrossRef
8. Identification of a novel pyridine derivative with inhibitory activity against ovarian cancer progression in vivo and in vitro
   Lulu Si et al, 2022, Frontiers in Pharmacology CrossRef
9. Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability
   Giorgio Milazzo et al, 2020, Genes CrossRef
10. HDAC6 Degradation Inhibits the Growth of High-Grade Serous Ovarian Cancer Cells
    Ahlam Ali et al, 2020, Cancers CrossRef
11. CUDC-907 exhibits potent antitumor effects against ovarian cancer through multiple in vivo and in vitro mechanisms
    Yuanpei Wang et al, 2024, Cancer Chemotherapy and Pharmacology CrossRef
12. Histone Modifying Enzymes in Gynaecological Cancers
    Priya Ramarao-Milne et al, 2021, Cancers CrossRef